Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Controlled Crystallization Enables Facile Fine-Tuning of Physical-Chemical Properties of Nicergoline Toward Easier Processability

BB. Prudilová, R. Gabriel, M. Otyepka, E. Otyepková

. 2025 ; 18 (10) : . [pub] 20250929

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc26002281

Background/Objectives: Crystallization is a key process in the manufacturing of active pharmaceutical ingredients (APIs), as it significantly affects the physical and chemical properties of the final product. Nicergoline, a clinically relevant ergot derivative, was chosen as a model compound to investigate how different crystallization strategies affect particle attributes. The objective of this study was to compare controlled and uncontrolled crystallization techniques and evaluate their impact on the physicochemical properties of nicergoline. Methods: Nicergoline was crystallized using controlled methods, including sonication-induced and seeding-induced crystallization, and uncontrolled methods, namely cubic and linear cooling, as well as acetone evaporation. The resulting powders were characterized by using a range of physicochemical techniques to assess particle morphology, size distribution, agglomeration behavior, and surface properties. Results: Uncontrolled crystallization methods produced particles prone to agglomeration, resulting in a broader particle size distribution ranging from 8 to 720 μm and heterogeneous surface characteristics. In contrast, controlled crystallization generated more uniform particles with reduced agglomeration and narrower particle size distributions. Among the evaluated methods, sonocrystallization provided the most effective control over particle size and morphology, demonstrated by a narrow size distribution ranging from 16 to 39 μm which correlated with improved flowability and surface energy. Conclusions: The study demonstrates that the choice of crystallization method significantly influences the structural and physicochemical properties of nicergoline. These findings highlight the importance of method selection for tailoring API properties to enhance downstream processing and product quality.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc26002281
003      
CZ-PrNML
005      
20260122082803.0
007      
ta
008      
260116s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ph18101465 $2 doi
035    __
$a (PubMed)41155580
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Prudilová, Barbora Blahová $u Department of Physical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 12, 771 46 Olomouc, Czech Republic $u Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic $1 https://orcid.org/000000032419560X
245    10
$a Controlled Crystallization Enables Facile Fine-Tuning of Physical-Chemical Properties of Nicergoline Toward Easier Processability / $c BB. Prudilová, R. Gabriel, M. Otyepka, E. Otyepková
520    9_
$a Background/Objectives: Crystallization is a key process in the manufacturing of active pharmaceutical ingredients (APIs), as it significantly affects the physical and chemical properties of the final product. Nicergoline, a clinically relevant ergot derivative, was chosen as a model compound to investigate how different crystallization strategies affect particle attributes. The objective of this study was to compare controlled and uncontrolled crystallization techniques and evaluate their impact on the physicochemical properties of nicergoline. Methods: Nicergoline was crystallized using controlled methods, including sonication-induced and seeding-induced crystallization, and uncontrolled methods, namely cubic and linear cooling, as well as acetone evaporation. The resulting powders were characterized by using a range of physicochemical techniques to assess particle morphology, size distribution, agglomeration behavior, and surface properties. Results: Uncontrolled crystallization methods produced particles prone to agglomeration, resulting in a broader particle size distribution ranging from 8 to 720 μm and heterogeneous surface characteristics. In contrast, controlled crystallization generated more uniform particles with reduced agglomeration and narrower particle size distributions. Among the evaluated methods, sonocrystallization provided the most effective control over particle size and morphology, demonstrated by a narrow size distribution ranging from 16 to 39 μm which correlated with improved flowability and surface energy. Conclusions: The study demonstrates that the choice of crystallization method significantly influences the structural and physicochemical properties of nicergoline. These findings highlight the importance of method selection for tailoring API properties to enhance downstream processing and product quality.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gabriel, Roman $u Department of Physical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 12, 771 46 Olomouc, Czech Republic $u TAPI Czech Industries s.r.o., Research & Development, Ostravská 29, 747 70 Opava, Czech Republic
700    1_
$a Otyepka, Michal $u Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic $u IT4Innovations, VSB-Technical University of Ostrava, 17. Listopadu 2172/15, 708 00 Ostrava-Poruba, Czech Republic $1 https://orcid.org/0000000210665677 $7 mzk2004257598
700    1_
$a Otyepková, Eva $u Department of Physical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 12, 771 46 Olomouc, Czech Republic $1 https://orcid.org/0000000204324868 $7 mzk2013786186
773    0_
$w MED00184066 $t Pharmaceuticals $x 1424-8247 $g Roč. 18, č. 10 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/41155580 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20260116 $b ABA008
991    __
$a 20260122082748 $b ABA008
999    __
$a ok $b bmc $g 2470441 $s 1267998
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 18 $c 10 $e 20250929 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
LZP    __
$a Pubmed-20260116

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...